补胞汤改善肾阳虚型黄体功能不全不孕症的临床观察

徐道芬; 孙云; 胡欣欣; 高楚楚; 郑慧君

doi:10.16766/j.cnki.issn.1674-4152.002251

补胞汤改善肾阳虚型黄体功能不全不孕症的临床观察

doi: 10.16766/j.cnki.issn.1674-4152.002251

温州市中医院妇科，浙江温州 325000

基金项目:

浙江省中医科技计划项目 2017ZQ025

温州市基础性科研项目 Y20190718

温州市科技局重大科技专项项目 ZS2017019

详细信息

通讯作者:
孙云，E-mail：23813959@qq.com

中图分类号: R711.6 R242
计量
- 文章访问数: 95
- HTML全文浏览量: 52
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2020-05-12
- 网络出版日期: 2022-03-02

Clinical observation of Bu Bao Decoction in improving infertility with luteal insufficiency caused by kidney yang deficiency type

Department of Gynecology, Wenzhou Traditional Chinese Medicine Hospital, Wenzhou, Zhejiang 325000, China

摘要

摘要: 目的探讨补胞汤对肾阳虚型黄体功能不全不孕症的改善效果及对子宫内膜血流动力学的作用，分析用药的安全性。方法选取2018年3月—2019年11月就诊于温州市中医院妇科门诊的黄体功能不全性不孕症患者80例，按随机数字表法分为观察组(40例)和对照组(40例)。观察组给予补胞汤，对照组口服地屈孕酮片。连续治疗3个月经周期后观察2组患者临床疗效，采用中医肾阳虚症状积分观察患者症状改善情况，检测2组患者黄体中期血清雌二醇(E₂)、孕酮(P)水平；超声检测患者治疗前后黄体中期子宫内膜厚度、子宫动脉血流阻力指数(RI)及搏动指数(PI)；随访6个月，记录2组患者临床妊娠情况以及不良反应发生情况。结果观察组临床有效率明显高于对照组[87.50%(35/40) vs. 67.50%(27/40)，Z=4.588，P=0.032]；治疗后观察组中医肾阳虚症状积分低于对照组，黄体中期血清E₂、P水平高于对照组(t=9.046、4.507、5.143, 均P < 0.05)；观察组治疗后子宫内膜厚度高于对照组，RI、PI低于对照组(t=5.228、4.005、2.923, 均P < 0.05)；随访6个月，观察组临床妊娠率高于对照组(χ²=4.267，P=0.039)；2组不良反应发生情况比较差异无统计学意义(P=0.999)。结论补胞汤治疗肾阳虚型黄体功能不全的不孕症患者疗效显著，能够明显改善患者黄体指标，提高妊娠率。
- 补胞汤 /
- 肾阳虚型 /
- 黄体功能不全 /
- 不孕症
Abstract: Objective To investigate the clinical efficacy of Bu Bao Decoction in improving infertility with luteal insufficiency caused by kidney yang deficiency type and its effect on the endometrial haemodynamics, and analyse the safety during medication. Methods Eighty infertility patients with luteal insufficiency who were treated in Wenzhou Traditional Chinese Medicine Gynecology Clinic from January 2018 to March 2019 were selected and randomly divided into the observation group (40 cases) and control group (40 cases). The observation group was given Bu Bao Decoction, While the control group was given dydrogesterone tablets. The patients in both groups were treated continuously for three menstrual cycles. The clinical efficacy of the two groups, the improvement of kidney yang deficiency symptoms and the serum estradiol (E₂) and progesterone (P) levels in the metaphase luteum were observed. Endometrial thickness, uterine artery blood flow resistance index (RI) and pulsatility index (PI) of patients were detected by ultrasound before and after treatment. Six-month follow-up was used to record the clinical pregnancy and adverse reactions in the two groups. Results The clinical effectiveness of the observation group was significantly higher than that of the control group [(35/40, 87.50%) vs. (27/40, 67.50%)], and the difference was statistically significant (Z=4.588, P=0.032). After treatment, the score of TCM kidney yang deficiency syndrome in the observation group was lower than that of the control group, and the serum E₂ and P levels in the metaphase luteum were higher than those in the control group, the difference was statistically significant (t=9.046, 4.507, 5.143, all P < 0.05). The endometrial thickness of the observation group after treatment was higher than that of the control group, while RI and PI were lower than the control group, the difference was statistically significant (t=5.228, 4.005, 2.923, all P < 0.05). After follow-up for 6 months, the clinical pregnancy rate of the observation group was higher than that of the control group, and the difference was statistically significant (χ²=4.267, P=0.039). No statistically significant difference in the occurrence of adverse reactions was found between the two groups during treatment (P=0.999). Conclusion Bu Bao Decoction has a significant effect on treating infertility patients with luteum insufficiency caused by kidney yang deficiency. Moreover, it can significantly improve the luteum index and increase the pregnancy rate.
- Bu Bao Decoction /
- Type of kidney yang deficiency /
- Luteal insufficiency /
- Infertility

HTML全文

图 1 典型子宫动脉治疗前后图像

注：A为例1治疗前，B为例1治疗后，C为例2治疗前，D为例2治疗后。

下载: 全尺寸图片幻灯片

表 1 2组黄体功能不全型不孕患者临床疗效比较[例(%)]

组别	例数	痊愈	显效	有效	无效	总有效
观察组	40	17(42.50)	10(25.00)	8(20.00)	5(12.50)	35(87.50)
对照组	40	11(27.50)	10(25.00)	6(15.00)	13(32.50)	27(67.50)
注：2组疗效比较，Z=4.588，P=0.032。

下载: 导出CSV

表 2 2组黄体功能不全型不孕患者中医肾阳虚症状积分和血清E₂、P水平比较(x±s)

组别	例数	中医肾阳虚症状积分(分)		E₂(pmol/L)		P(nmol/L)
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	40	18.71±2.94	7.11±1.23	436.08±37.65	555.47±45.69	17.43±2.05	51.73±8.44
对照组	40	18.26±2.79	10.24±1.81	441.02±40.59	511.23±42.03	17.18±1.99	42.56±7.48
t值		0.702	9.046	0.564	4.507	0.553	5.143
P值		0.485	< 0.001	0.574	< 0.001	0.582	< 0.001

下载: 导出CSV

表 3 2组黄体功能不全型不孕患者子宫内膜厚度及子宫动脉血流相关参数比较(x±s)

组别	例数	子宫内膜厚度(mm)		PI		RI
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	40	3.77±0.69	7.39±1.03	2.65±0.54	1.47±0.33	0.91±0.09	0.82±0.06
对照组	40	3.72±0.71	6.18±1.04	2.62±0.61	1.86±0.52	0.92±0.08	0.87±0.09
t值		0.319	5.228	0.233	4.005	0.525	2.923
P值		0.750	< 0.001	0.816	< 0.001	0.601	0.004

下载: 导出CSV

参考文献(20)

[1]	黄永俐, 沈洁. 不孕症妇女的危险因素研究[J]. 中国妇产科临床杂志, 2018, 19(1): 65-66. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201801024.htm
[2]	OZDEMIR T R, OZYILMAZ B, CAKMAK O, et al. Evaluation of chromosomal abnormalities and Y-chromosome microdeletions in 1696 Turkish cases with primary male infertility: A single-center study[J]. Turk J Urol, 2019, 46(2): 95-100.
[3]	姚祺, 黄美霞, 李一妹. 地屈孕酮联合黄体酮对黄体功能不足性流产患者的临床疗效及对细胞因子的影响[J]. 生殖医学杂志, 2017, 26(7): 694-698. doi: 10.3969/j.issn.1004-3845.2017.07.015
[4]	尚玉洁, 陈赟, 卢苏. 补肾活血中药治疗早发性卵巢功能不全的Meta分析[J]. 中华中医药学刊, 2018, 36(10): 2448-2454. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201810038.htm
[5]	陈子江. 不孕症诊断标准及其解读[C]. 第七次全国妇科内分泌学术会议论文汇编, 济南, 2013.
[6]	李炜弘, 严石林, 汤朝晖, 等. 肾阳虚证辨证诊断标准的专家评价[C]. 中华中医药学会中医诊断学分会第十次学术研讨会论文集, 咸阳, 2009: 109-114.
[7]	黄腾辉. 肾虚证症状量化等级评判标准的研究[J]. 卫生职业教育, 2005, 23(21): 108-110. doi: 10.3969/j.issn.1671-1246.2005.21.078
[8]	陈廷贵, 杨思澍. 实用中西医结合诊断治疗学[M]. 北京: 中国医药科技, 1991: 890-1025.
[9]	EL Z A E, LI R, ZHENG Y, et al. Deletion of RhoA in progesterone receptor-expressing cells leads to luteal insufficiency and infertility in female mice[J]. Endocrinology, 2017, 158(7): 2168-2178. doi: 10.1210/en.2016-1796
[10]	杨丽洁, 吴节, 杨林, 等. "调冲任、固肾元"针灸法对黄体功能不全患者卵泡发育及妊娠结局的影响[J]. 中国针灸, 2019, 39(9): 927-931. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201909005.htm
[11]	胡天惠. 安坤种子丸对改善黄体功能不全性不孕症患者子宫内膜容受性的临床研究[D]. 兰州: 甘肃中医学院, 2014.
[12]	陈志梅, 马大正, 雷丽红, 等. 补胞汤对胚泡着床障碍小鼠子宫内膜容受性的影响[J]. 江西中医药, 2011, 42(3): 15-17. doi: 10.3969/j.issn.0411-9584.2011.03.008
[13]	孙云. 移植前应用补胞汤对体外受精-胚胎移植结局的影响[J]. 新中医, 2013, 45(4): 61-63. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201304026.htm
[14]	马堃, 李敏. 补肾促卵冲剂治疗排卵障碍性不孕"肾虚血瘀"作用机制的研究[J]. 中国中药杂志, 2017, 42(23): 4445-4450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201723001.htm
[15]	MA S H, MA R H, XIA T, et al. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: Study protocol for a randomized controlled trial[J]. Trials, 2018, 19(1): 124. doi: 10.1186/s13063-018-2511-0
[16]	马苗, 凌娜, 施晓玲. 中药联合黄体酮胶丸治疗肾阳虚型黄体功能不全性不孕症临床观察[J]. 辽宁中医药大学学报, 2018, 20(11): 193-195. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201811061.htm
[17]	韩春艳, 上官文庆, 孙自学. 毓麟助孕方治疗肾阳虚型排卵障碍性不孕症[J]. 中药材, 2018, 41(12): 2938-2941. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCA201812043.htm
[18]	BOWDRIDGE E C, VERNON M W, FLORES J A, et al. In vitro progesterone production by luteinized human mural granulosa cells is modulated by activation of AMPK and cause of infertility[J]. Reprod Biol Endocrinol, 2017, 15(1): 76. doi: 10.1186/s12958-017-0295-9
[19]	刘元文, 刘金星. 补肾调冲汤治疗肾阳虚血瘀型黄体功能不全性不孕症临床研究[J]. 山东中医杂志, 2018, 37(9): 734-737. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY201809008.htm
[20]	綦向军, 张兆萍, 章浩展, 等. 基于数据挖掘的名老中医治疗不孕的用药规律分析[J]. 中国中药杂志, 2019, 44(7): 1491-1496. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201907021.htm